Knowledge Center

How To Insights

How To Insight

The Importance of Prioritizing Indications for Cell and Gene Therapy-Focused Companies

Prioritizing an indication for a cell or gene therapy asset is a multistep process but a necessary part of a biotech’s evolution and ultimate success.…

How To Insight

Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market

Kineticos takes an immersive stance with its biotech engagements and investments, working closely in a collaborative effort with key leadership roles in the companies they…

How To Insight

The Importance of Medical Affairs for Market Access and Commercial Success

Gaining market access is a complicated process, and it requires coordinated management of a list of complex and challenging activities. One of these challenging activities…

How To Insight

Utilizing Primary Research to Understand the Reimbursement Landscape

Reimbursement becomes an integral piece to any diagnostic test or procedure or medical device as you prepare for commercialization. Understanding the reimbursement landscape can become…

How To Insight

Building a Biotech Licensing Deal Structure for A Successful Partnering Engagement

When clients initially engage Kineticos for business development and licensing support, many have not yet considered the desired deal structure they seek for their assets,…

How To Insight

How to Conduct Market Diligence for Cell Therapy Safety Testing

Cell therapy is a rapidly growing market, with the FDA expecting 200 new INDs and 10-20 approvals of cell and gene therapy products by 2025.

How To Insight

How to Perform a Biotech Commercial Assessment

Due to the unique factors of CAR-T therapy, a commercial assessment is an even more critical tool than usual in the toolkit of building a…

How To Insight

The Benefits of a Robust Target Product Profile

As a drug candidate enters the clinical development stage, it is essential that all stakeholders understand and share the same aspirational targets for the prioritized…

How To Insight

Primary Research and View of the Future

It’s critical to understand the current landscape for each client’s service offerings, but understanding what respondents recognize as critical headwinds and tailwinds in the next…

How To Insight

Hiring Top Talent You Want Today and Need Tomorrow

The Life Sciences market continues to outpace all industries in growth, and the competition for top talent is fierce. In this follow-up article, I focus…

How To Insight

Using a Primary Research Study to Conduct Pricing Analysis

The pricing section of a primary research study is often considered the most important section for our biotech clients when conducting primary research. It is…

How To Insight

Employees Will Be This Decade’s Disruptive Change Agents

As a leader of a company, and as a leader of people, you anticipate unexpected and even disruptive change within your markets, but have you…

How To Insight

How to Conduct Competitive Intelligence Using a Primary Research Study

In a dynamic and fast-changing life sciences landscape, gaining a deep understanding of how you are positioned against your top competitors is critical to your…

How To Insight

How the Right Customer Buying Preference Questions Can Support Strategic Planning for Biotech Companies

Understanding what drives customer choice is a critical component of a company’s strategic planning; whether the company has maintained a strong market presence for many…

How To Insight

Fail Early, Fail Fast

“Biotech executives are addressing a multitude of strategic priorities daily. However, prioritizing indications and executing the right portfolio program are becoming more challenging. If you…

How To Insight

If You Want Real Answers to Your Questions, Then Ask The Right People!

“When consulting firms execute corporate strategy projects, they typically employ secondary research solely, which is publicly available information. Secondary research is a static view –…